Empire Financial Management Company’s Vanda Pharmaceuticals VNDA Stock Holding History

Empire Financial Management Company’s Portfolio VNDA Stock Details VNDA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$6.37M	Sell	922,245 -186,000	-17%	-$1.43M	1.44%	14
2025 Q4	$9.77M	Buy	1,108,245 +350,154	+46%	+$1.93M	2.12%	9
2025 Q3	$3.78M	Buy	758,091 +563,091	+289%	+$2.61M	0.87%	34
2025 Q2	$920K	Buy	195,000 +45,000	+30%	+$197K	0.27%	104
2025 Q1	$689K	Buy	150,000 +86,000	+134%	+$401K	0.21%	117
2024 Q4	$307K	Buy	+64,000	New	+$307K	0.1%	169
2024 Q2	–	Sell	-65,000	Closed	-$267K	–	218
2024 Q1	$267K	Buy	+65,000	New	+$260K	0.09%	180

Other funds holding VNDA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ACM

AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Empire Financial Management Company's VNDA Position: Q1 2026 in Review

Empire Financial Management Company reduced its Vanda Pharmaceuticals (VNDA) stake by 17% in Q1 2026, selling an estimated $1.43M and leaving 922,245 shares worth $6.37M. The position accounts for 1.44% of the portfolio, ranked #14.

Empire Financial Management Company first reported a position in VNDA in Q1 2024 and has held it in 7 quarters since. The position peaked at $9.77M in Q4 2025. 170 funds tracked by Wall St. Rank hold VNDA as of Q1 2026.

Empire Financial Management Company held 922,245 shares of Vanda Pharmaceuticals worth $6.37M as of Q1 2026.
Empire Financial Management Company sold 186,000 Vanda Pharmaceuticals shares in Q1 2026, an estimated $1.43M.
Vanda Pharmaceuticals made up 1.44% of Empire Financial Management Company's portfolio in Q1 2026, its #14 holding.
Empire Financial Management Company first reported a position in Vanda Pharmaceuticals in Q1 2024 and has held it in 7 quarters since.
Empire Financial Management Company's Vanda Pharmaceuticals position peaked at $9.77M in Q4 2025.
170 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q1 2026.

Based on Empire Financial Management Company's 13F filing for Q1 2026, filed 18 May 2026.